DABUR:NSEDabur India Limited Analysis
Data as of 2026-03-15 - not real-time
₹453.50
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Dabur India is trading near a strong support level of around ₹452, with the current price just above that threshold. Technical indicators show a bearish MACD and price below the 20‑, 50‑ and 200‑day SMAs, yet the RSI sits in oversold territory, hinting at a possible short‑term bounce. Fundamentally, the company delivered 6.1% YoY revenue growth in Q3 FY26, driven by a 6% rise in domestic FMCG sales and a 10% increase in PAT, underscoring resilient earnings momentum. The balance sheet is cash‑rich, holding roughly three times more cash than debt, and the dividend payout ratio of 77% appears sustainable at the current 1.76% yield. However, valuation multiples remain elevated, with a trailing PE above 40 and a price‑to‑book near 7.5, suggesting the stock is priced for growth. Analyst consensus points to a median target of ₹542.5, implying roughly 20% upside from today’s level. Given the blend of defensive sector characteristics, low beta, and solid cash generation, the medium‑ to long‑term outlook is positive, but short‑term price action may remain choppy as the market tests the support zone.
Investors should monitor the support level and any reversal signals from the RSI, while also keeping an eye on upcoming earnings for confirmation of the growth trajectory. The defensive nature of the consumer staples sector, combined with a stable dividend and strong cash position, supports a buy recommendation for the medium and long horizons, whereas a cautious hold is prudent in the immediate term.
Investors should monitor the support level and any reversal signals from the RSI, while also keeping an eye on upcoming earnings for confirmation of the growth trajectory. The defensive nature of the consumer staples sector, combined with a stable dividend and strong cash position, supports a buy recommendation for the medium and long horizons, whereas a cautious hold is prudent in the immediate term.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- price testing strong support around ₹452
- MACD remains bearish indicating downward momentum
- RSI in oversold region suggesting potential rebound
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- 6% YoY revenue growth driven by hair oil and FMCG segments
- robust cash position offsetting a high debt‑to‑equity ratio
- analyst median target price of ₹542.5 implying ~20% upside
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- well‑established brand with diversified product portfolio in a defensive sector
- sustainable dividend payout supported by strong cash generation
- low beta indicating defensive characteristics and resilience to market swings
Key Metrics & Analysis
Financial Health
Revenue Growth6.10%
Profit Margin14.22%
P/E Ratio43.6
Debt/Equity11.46
P/B Ratio7.3
Technical Analysis
TrendNeutral
RSI28.6
Support₹452.05
Resistance₹525.50
MA 20₹497.66
MA 50₹507.64
MA 200₹507.54
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Target Price₹549.74
Upside/Downside21.22%
GradeFair
TypeBlend
Dividend Yield1.76%
Risk Assessment
Beta0.12
Volatility24.33%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.